The global health burden due to glaucoma is large and growing. In response to this important trend, for the next several years, the journal is committed to making discoveries and innovations in the clinical management of glaucoma a high priority. As part of this effort, the journal is dedicating this and future feature issues to the topic of glaucoma for the next several years.
This feature issue will focus on research related to intraocular pressure (IOP) in glaucoma, a very broad and active field of investigation. The link between elevated IOP and glaucoma is so well established that it has been characterized as a causative disease factor. Moreover, lowering IOP remains the primary target for glaucoma therapy.
Optometry and Vision Science believes that it is timely to bring ongoing research efforts to publication in a feature theme issue that informs and advances thinking on this topic for researchers and clinicians alike. I am especially pleased to recognize the contributions of our guest editors who contributed to this feature issue.
Dr. Mick was appointed as an Associate Editor for Optometry and Vision Science in January 2017. He is a graduate of UC Berkeley School of Optometry and practices at The San Francisco Veterans Administration (SFVA) Medical Center (San Francisco, CA). He is also the current SFVA Residency Program Coordinator. He is a frequent clinical educator with recognized expertise in glaucoma diagnosis and management. He is the past chair of the American Academy of Optometry's Scientific Program Committee and served on the committee for the past 10 years. The Academy's Scientific Program Committee serves to advance the quality of scientific content presented at the annual meeting.
Dr. Anderson is a highly respected contributor to the clinical and research knowledge base of glaucoma. He has more than 250 publications with more than 12,000 citations to his work, which spans virtually every aspect of this disease, from elevated IOP to low-tension glaucoma, visual field interpretation, and ocular blood flow. It is fair to say that Dr. Anderson has contributed greatly to our modern understanding and clinical practices in the care of patients with glaucoma. He is also a frequent contributor to the Optometric Glaucoma Society's annual program.
Dr. Downs brings a unique blend of engineering and biomedicine to the field of glaucoma research. For decades, he has advanced our understanding of IOP measurement and the interactions of pressure fluctuations on the physical structural components of the eye. His groundbreaking work on ocular biomechanics has deepened our understanding of how physical forces modulate the structural morphology of the optic nerve and progressive optic neuropathy of glaucoma.
Dr. Dreer investigates problems at the intersection of chronic disease, disability, and behavioral interventions to improve health outcomes. She has investigated the effects of glaucoma and visual disability since 2005 with a focus on medication adherence. She also brings expertise in the methodology of meta-analysis and systematic reviews.
Dr. Fingeret has devoted most of his career to advancing glaucoma care and education in the profession of optometry. He founded the Optometric Glaucoma Society with a group of collaborators who were similarly passionate about improving care and provider competency in glaucoma.
Dr. Freddo's career contributions have been rooted in education and the fundamentals of ocular disease pathophysiology with special emphasis on glaucoma and anterior segment manifestations. He has been a leader in optometric research and education for more than 30 years. Dr. Freddo has more than 80 peer-reviewed publications with more than 1700 citations to his work.
Dr. Johnson has been actively investigating glaucoma for more than 35 years. He has more than 250 publications and more than 10,000 citations to his work. Dr. Johnson has been an active member of the Ocular Hypertension Treatment Study for more than 20 years and has participated in countless studies investigating the causes, diagnostic innovations, clinical assessments, and effectiveness of treatments for glaucoma.
Dr. Liu's research has advanced our understanding of IOP and its relation, optic neuropathy. For decades, Dr. Liu has investigated IOP dynamics in humans and in animal models of disease. Groundbreaking work led by Dr. Liu in the late 1990s characterized the diurnal rhythms of IOP in humans that preceded the availability of today's wireless sensing contact lenses. Dr. Liu is widely recognized for his foundational contributions to our understanding of factors that influence IOP and their importance in glaucoma management.
I hope you will find this feature issue informative and that it will help stimulate your curiosity and passion for understanding glaucoma and its current clinical management.
Michael D. Twa
Editor in Chief